REQUEST A DEMO
Total
USD $0.00
Search more companies

Icon Clinical Research S.R.O. (Czech Republic)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Icon Clinical Research S.R.O. Profile Updated: October 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Icon Clinical Research S.R.O. is a company in Czech Republic, with a head office in Prague. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences sector. The enterprise was incorporated on October 12, 2007. 100 - 199 (2023) employees currently work for Icon Clinical Research S.R.O.. In 2022, the company reported a net sales revenue increase of 32.9%. Its’ total assets recorded a growth of 24%. In 2022, Icon Clinical Research S.R.O.’s net profit margin increased by 0.17%.

Headquarters
V parku 2335/20
Prague; The City of Prague; Postal Code: 14800

Contact Details: Purchase the Icon Clinical Research S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Icon Clinical Research S.R.O. report to view the information.
Outstanding Shares:
Purchase the Icon Clinical Research S.R.O. report to view the information.
Registered Capital:
Purchase the Icon Clinical Research S.R.O. report to view the information.
Incorporation Date:
October 12, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Icon Clinical Research S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
32.9%
Total operating revenue
32.9%
Operating profit (EBIT)
54.11%
EBITDA
52.32%
Net Profit (Loss) for the Period
36.85%
Total assets
24%
Total equity
19.49%
Operating Profit Margin (ROS)
0.84%
Net Profit Margin
0.17%
Return on Equity (ROE)
2.07%
Quick Ratio
-1.21%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?